Trial results
$KROS — rinvatercept
Keros Therapeutics, Inc. (KROS) rinvatercept: trial results in Duchenne muscular dystrophy (DMD), 2027.
- Event id
KROS-RINVATERCEPT-2026- Company
- Keros Therapeutics, Inc.
- Kind
- Trial results
- Indication
- Duchenne muscular dystrophy (DMD)
- Window
- 2027-01-01 – 2027-06-30
- Status
- dropped
The bar
No bar has been published for this event yet.
Verdicts
No verdict has been published for this event yet.